Altered distribution of β-catenin and prognostic roles in colorectal carcinogenesis
Authors:
- 1 January 2008
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 43 (4) , 456-464
Abstract
Objective. Although β-catenin cytoplasmic stabilization and nuclear translocation play a key role in initiation of colorectal cancer (CRC), the mechanisms are far from clear. The aim of this study was to investigate the relation of expressions of cyclooxygenase (COX)-2 and E-cadherin, and the β-catenin gene exon 3 mutation to the altered distribution of β-catenin, and their roles in CRC progression and prognosis. Material and methods. Expressions of β-catenin, COX-2 and E-cadherin in 96 tissue specimens were detected by immunohistochemistry, and mutation of β-catenin gene exon 3 was screened by polymerase chain reaction (PCR) and denaturing high-performance liquid chromatography (DHPLC). Results. Cytoplasmic/nuclear expression of β-catenin and reduced membranous expression of E-cadherin were associated, respectively, with the earlier and later stages of sequential colorectal carcinogenesis (p<0.05). The altered distribution of β-catenin was significantly associated with both high Dukes’ stages and poor differentiation of CRC (p<0.05). It also had a parallel relationship with COX-2 overexpression (p<0.05, Spearman's rank analysis), but not with reduced E-cadherin expression. Kaplan-Meier analysis showed a significantly worse survival rate for CRC patients with altered expression of β-catenin (pβ-catenin gene in all 60 cases of CRC. Conclusions. Altered distribution of β-catenin occurs in the early stage of colorectal carcinogenesis and has a parallel relationship with COX-2 overexpression. It may serve as a potential marker for the progression and prognosis of CRC. The exon 3 mutation did not appear contributive to the abnormal expression of β-catenin in CRCs in a Chinese population.Keywords
This publication has 29 references indexed in Scilit:
- Balancing cell adhesion and Wnt signaling, the key role of β-cateninCurrent Opinion in Genetics & Development, 2006
- Prognostic value of E-cadherin, beta-catenin, MMPs (7 and 9), and TIMPs (1 and 2) in patients with colorectal carcinomaJournal of Surgical Oncology, 2006
- Immunohistochemical investigation of tumorigenic pathways in small intestinal adenocarcinoma: a comparison with colorectal adenocarcinomaLaboratory Investigation, 2006
- Prostaglandin E2 Stimulates the β-Catenin/T Cell Factor-dependent Transcription in Colon CancerJournal of Biological Chemistry, 2005
- Expression of E-Cadherin, β-Catenin, and CD-44v6 cell adhesion molecules in Primary Tumors and Metastases of Colorectal AdenocarcinomaBulletin of Experimental Biology and Medicine, 2005
- Quantification of Plasma β-Catenin mRNA in Colorectal Cancer and Adenoma PatientsClinical Cancer Research, 2004
- Translocation of β-catenin into the nucleus independent of interactions with FG-rich nucleoporinsExperimental Cell Research, 2003
- Inflammation and cancerNature, 2002
- Mechanism and function of signal transduction by the Wnt/β-catenin and Wnt/Ca2+ pathwaysOncogene, 1999
- Relationship of β-catenin and Bcl-2 expression to sulindac-induced regression of intestinal tumors in Min miceCarcinogenesis, 1999